pI: 6.1851 |
Length (AA): 972 |
MW (Da): 109660 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 929 | 5c0w (J) | 19 | 1001 | 36.00 | 0 | 1 | 1.2666 | 0.34 |
56 | 200 | 2hww (B) | 1246 | 1416 | 19.00 | 0 | 0.78 | 0.259877 | -0.58 |
367 | 878 | 4ro1 (A) | 332 | 896 | 33.00 | 0 | 1 | 0.888649 | 0.05 |
887 | 948 | 2a19 (A) | 37 | 106 | 18.00 | 0.26 | 0.02 | 0.251686 | -0.19 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_127058)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G17510 | ribonuclease II family protein |
Babesia bovis | BBOV_I003540 | RNB-like domain containing protein |
Brugia malayi | Bm1_17655 | RNB-like protein |
Candida albicans | CaO19.12694 | similar to S. cerevisiae DIS3 (YOL021C) exosome component involved mRNA degradation and nuclear RNA processing |
Candida albicans | CaO19.5229 | similar to S. cerevisiae DIS3 (YOL021C) exosome component involved mRNA degradation and nuclear RNA processing |
Caenorhabditis elegans | CELE_C04G2.6 | Protein DIS-3 |
Cryptosporidium hominis | Chro.20227 | mitotic control protein dis3 |
Cryptosporidium parvum | cgd2_2090 | mitotic control protein dis3, putative |
Chlamydia trachomatis | CT_397 | ribonuclease R |
Dictyostelium discoideum | DDB_G0293614 | hypothetical protein |
Dictyostelium discoideum | DDB_G0268186 | hypothetical protein |
Drosophila melanogaster | Dmel_CG6413 | CG6413 gene product from transcript CG6413-RA |
Escherichia coli | b4179 | exoribonuclease R, RNase R |
Echinococcus granulosus | EgrG_000518000 | dis3 exonuclease 1 |
Entamoeba histolytica | EHI_160720 | exosome complex exonuclease, putative |
Echinococcus multilocularis | EmuJ_000518000 | dis3 exonuclease 1 |
Giardia lamblia | GL50803_112718 | Mitotic control protein dis3 |
Homo sapiens | ENSG00000166938 | DIS3 like exosome 3'-5' exoribonuclease |
Homo sapiens | ENSG00000083520 | DIS3 exosome endoribonuclease and 3'-5' exoribonuclease |
Leishmania braziliensis | LbrM.28.0340 | rrp44p homologue, putative |
Leishmania donovani | LdBPK_280470.1 | rrp44p homologue, putative |
Leishmania infantum | LinJ.28.0470 | rrp44p homologue, putative |
Leishmania major | LmjF.28.0330 | rrp44p homologue, putative |
Leishmania mexicana | LmxM.28.0330 | rrp44p homologue, putative |
Loa Loa (eye worm) | LOAG_02690 | hypothetical protein |
Mus musculus | ENSMUSG00000032396 | DIS3 mitotic control homolog (S. cerevisiae)-like |
Mus musculus | ENSMUSG00000033166 | DIS3 mitotic control homolog (S. cerevisiae) |
Neospora caninum | NCLIV_026230 | DIS3-like exonuclease 1 (EC 3.1.13.-), related |
Oryza sativa | 4331494 | Os03g0129200 |
Plasmodium berghei | PBANKA_1135600 | exosome complex exonuclease RRP44, putative |
Plasmodium falciparum | PF3D7_1359300 | exosome complex exonuclease RRP44 |
Plasmodium knowlesi | PKNH_1112000 | exosome complex exonuclease RRP44, putative |
Plasmodium vivax | PVX_114935 | exosome complex exonuclease RRP44, putative |
Plasmodium yoelii | PY02885 | hypothetical protein |
Plasmodium yoelii | PY06658 | probable mitotic control protein dis3 |
Saccharomyces cerevisiae | YOL021C | exosome catalytic subunit DIS3 |
Schistosoma japonicum | Sjp_0071900 | DIS3-like exonuclease 1, putative |
Schistosoma japonicum | Sjp_0071890 | ko:K01149 DIS3 mitotic control homolog [EC:3.1.13.-], putative |
Schistosoma mansoni | Smp_161980 | ribonuclease II-related |
Schmidtea mediterranea | mk4.001720.00 | DIS3-like exonuclease 1 |
Schmidtea mediterranea | mk4.031335.00 | |
Schmidtea mediterranea | mk4.037021.03 | |
Schmidtea mediterranea | mk4.054278.02 | |
Schmidtea mediterranea | mk4.031335.01 | |
Trypanosoma brucei gambiense | Tbg972.11.8560 | exosome complex exonuclease RRP44p homologue, putative |
Trypanosoma brucei | Tb11.02.5380 | exosome complex exonuclease RRP44p homologue |
Trypanosoma cruzi | TcCLB.508241.120 | rrp44p homologue, putative |
Toxoplasma gondii | TGME49_261050 | RNB family domain-containing protein |
Theileria parva | TP01_0496 | mitotic control protein dis3, putative |
Trichomonas vaginalis | TVAG_311220 | ribonuclease, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.5380 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.5380 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.5380 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.5380 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b4179 | Escherichia coli | non-essential | goodall |
CELE_C04G2.6 | Caenorhabditis elegans | slow growth | wormbase |
YOL021C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1135600 | Plasmodium berghei | Essential | plasmo |
TGME49_261050 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.